Research map: Immune Pathways in Doxorubicin Cardiotoxicity: A Cardio-Immunology Perspective

Back to the article

Papers in this map

  1. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease · Paul M. Ridker · 2017 · 9543 citations · Cited by this paper
  2. CRISPR/Cas9 Screens Implicate RARA and SPNS1 in Doxorubicin Cardiotoxicity · 2026 · Related
  3. Empagliflozin in Heart Failure with a Preserved Ejection Fraction · Stefan D. Anker · 2021 · 4865 citations · Cited by this paper
  4. Sacubitril/Valsartan in Anthracycline-Treated Patients · 2026 · Related
  5. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) · Alexander Richard Lyon · 2022 · 3064 citations · Cited by this paper
  6. Major Adverse Cardiovascular Events and Cardiac Dysfunction in Patients With Acute Leukemia · 2026 · Related
  7. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction · Scott David Solomon · 2022 · 2871 citations · Cited by this paper
  8. Screened But Unproven · 2026 · Related
  9. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 · Jonathan Kocarnik · 2021 · 2101 citations · Cited by this paper
  10. Treatment and Outcomes in Myocardial Infarction and Cancer—A German Real-Life Analysis · 2026 · Related
  11. Identification of the molecular basis of doxorubicin-induced cardiotoxicity · Sui Zhang · 2012 · 1989 citations · Cited by this paper
  12. Sotatercept for the Treatment of Myeloproliferative Neoplasm–Associated Group 5 Pulmonary Hypertension · 2026 · Related
  13. Cells of the adult human heart · Monika Litviňuková · 2020 · 1848 citations · Cited by this paper
  14. The Promise and Pitfalls of TTR Stabilization Assays in ATTR-CM · 2026 · Related
  15. Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy · Daniela Maria Cardinale · 2015 · 1763 citations · Cited by this paper
  16. Elevated Plasma IL-18 Levels During Chemotherapy Treatment for Breast Cancer, Exercise Capacity, and Physical Activity · 2026 · Related
  17. Doxorubicin: The Good, the Bad and the Ugly Effect · Cristina Carvalho · 2009 · 1517 citations · Cited by this paper
  18. Proactive Surveillance for ICI Cardiotoxicity · 2026 · Related
  19. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline · Saro H. Armenian · 2017 · 1312 citations · Cited by this paper
  20. Reply · 2026 · Related
  21. Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition · Daniela Maria Cardinale · 2006 · 1032 citations · Cited by this paper
  22. Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy · Daniela Maria Cardinale · 2004 · 958 citations · Cited by this paper
  23. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation · Yoshihiko Ichikawa · 2014 · 897 citations · Cited by this paper
  24. Cardioimmunology: the immune system in cardiac homeostasis and disease · Filip K. Świrski · 2018 · 871 citations · Cited by this paper
  25. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association · Laxmi S. Mehta · 2018 · 859 citations · Cited by this paper
  26. The Cardiovascular Biology of Glucagon-like Peptide-1 · Daniel J. Drucker · 2016 · 660 citations · Cited by this paper
  27. The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia · Steven E. Lipshultz · 2004 · 628 citations · Cited by this paper
  28. Crosstalk between fibroblasts and inflammatory cells · Sophie Van Linthout · 2014 · 574 citations · Cited by this paper
  29. Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis · Franco Locatelli · 2020 · 535 citations · Cited by this paper
  30. Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity · Mônica Samuel Ávila · 2018 · 510 citations · Cited by this paper
  31. DAMPs and DAMP-sensing receptors in inflammation and diseases · Ming Ma · 2024 · 505 citations · Cited by this paper
  32. Host and Environmental Factors Influencing Individual Human Cytokine Responses · Rob ter Horst · 2016 · 478 citations · Cited by this paper
  33. Cardiotoxicity of Anthracyclines · Daniela Maria Cardinale · 2020 · 462 citations · Cited by this paper
  34. Humoral Innate Immunity and Acute-Phase Proteins · Alberto Mantovani · 2023 · 310 citations · Cited by this paper
  35. Monocyte and macrophage contributions to cardiac remodeling · Maarten Hulsmans · 2015 · 286 citations · Cited by this paper
  36. In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing · Gabriel Courties · 2013 · 285 citations · Cited by this paper
  37. Targeting immune–fibroblast cell communication in heart failure · Junedh Amrute · 2024 · 267 citations · Cited by this paper
  38. Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity · Bin Bin Wu · 2022 · 242 citations · Cited by this paper
  39. Elevated Cardiac Troponin T in Patients With Skeletal Myopathies · Johannes Schmid · 2018 · 234 citations · Cited by this paper

Source: OpenAlex (CC0)